Epidermal growth factor receptor mutation-guided treatment for lung cancers: Where are we now?
- Published in:
- Thoracic Cancer, 2011, v. 2, n. 1, p. 1, doi. 10.1111/j.1759-7714.2010.00035.x
- By:
- Publication type:
- Article
Works matching IS 17597706 AND DT 2011 AND VI 2 AND IP 1
Results: 6
1
2
Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data.
- Published in:
- Thoracic Cancer, 2011, v. 2, n. 1, p. 16, doi. 10.1111/j.1759-7714.2010.00033.x
- By:
- Publication type:
- Article
3
Prevalence of low body mass index among newly diagnosed lung cancer patients in North India and its association with smoking status.
- Published in:
- Thoracic Cancer, 2011, v. 2, n. 1, p. 27, doi. 10.1111/j.1759-7714.2010.00037.x
- By:
- Publication type:
- Article
4
Application of hRad9 in lung cancer treatment as a molecular marker and a molecular target.
- Published in:
- Thoracic Cancer, 2011, v. 2, n. 1, p. 7, doi. 10.1111/j.1759-7714.2010.00036.x
- By:
- Publication type:
- Article
5
Isolated splenic metastasis of lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2011, v. 2, n. 1, p. 32, doi. 10.1111/j.1759-7714.2010.00031.x
- By:
- Publication type:
- Article
6
Uncommon cause of intrathoracic mass.
- Published in:
- Thoracic Cancer, 2011, v. 2, n. 1, p. 24, doi. 10.1111/j.1759-7714.2010.00034.x
- By:
- Publication type:
- Article